Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 178,901 | 182,913 | 192,962 | 209,990 | 42,487 |
| Marketable Securities | 37,712 | 60,606 | 72,357 | 70,566 | 21,647 |
| Receivables | 6,647 | 6,318 | 6,278 | 7,948 | 7,514 |
| Inventories | 5,756 | 5,042 | 5,729 | 4,502 | 3,667 |
| Other current assets | 5,580 | 5,018 | 5,529 | 7,819 | 4,930 |
| TOTAL | $234,596 | $259,897 | $282,855 | $300,825 | $80,245 |
| Non-Current Assets | |||||
| PPE Net | 4,659 | 4,431 | 4,663 | 4,045 | 2,559 |
| Intangibles | 17,896 | 16,810 | 15,673 | 14,331 | 13,899 |
| Other Non-Current Assets | 20,071 | 16,414 | 16,982 | 15,717 | 7,338 |
| TOTAL | $42,626 | $37,655 | $37,318 | $34,093 | $23,796 |
| Total Assets | $277,222 | $297,552 | $320,173 | $334,918 | $104,041 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,425 | 7,759 | 6,737 | 8,759 | 6,248 |
| Accrued Expenses | 16,396 | 15,287 | 15,972 | 12,641 | 10,750 |
| Other current liabilities | N/A | 12 | 12 | 227 | 2,859 |
| TOTAL | $30,961 | $30,118 | $28,603 | $27,757 | $24,907 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,186 | 5,173 | 4,069 | 4,742 | 4,083 |
| Other Non-Current Liabilities | 18,146 | 15,524 | 16,170 | 17,332 | 7,902 |
| TOTAL | $18,146 | $15,524 | $16,170 | $17,466 | $8,040 |
| Total Liabilities | $49,107 | $45,642 | $44,773 | $45,223 | $32,947 |
| Shareholders' Equity | |||||
| Common Shares | 3,464 | 3,464 | 3,328 | 3,328 | 2,529 |
| Retained earnings | -261,522 | -236,841 | -211,354 | -189,980 | -168,737 |
| Other shareholders' equity | 14,550 | 14,344 | 12,539 | 5,460 | 5,415 |
| TOTAL | $228,115 | $251,910 | $275,400 | $289,695 | $71,094 |
| Total Liabilities And Equity | $277,222 | $297,552 | $320,173 | $334,918 | $104,041 |